Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
92
NCT03320265
Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 11, 2017
Completion: Jul 3, 2018
NCT03991143
Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction
Start: Mar 29, 2019
Completion: Apr 19, 2021